Jennifer A. Svetlecic, M.D.

2.8 times the Medicare Part D claims of the average pulmonary disease physician in 2024

4,060 Medicare Part D claims for 531 beneficiaries, against an average of 1,425 among the 11,596 providers of this specialty who prescribed in Part D. Brand-name drugs were 59% of claims. 15 claims were for opioids.

Most prescribed

1. Trelegy Ellipta462 claims
2. Albuterol Sulfate Hfa452 claims
3. Montelukast Sodium293 claims
4. Anoro Ellipta226 claims
5. Fluticasone-Salmeterol213 claims
6. Arnuity Ellipta179 claims

Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.

The practice group's MIPS final score for 2023 (Medicare payment program): 77.3 of 100

The Merit-based Incentive Payment System score is reported for the practice group, not for one clinician alone. Four categories are weighted into the final score; the average among 454,083 clinicians with a measured score was 83.5.

Source: CMS Quality Payment Program, MIPS performance year 2023, group reporting; category weights for 2023 (qpp.cms.gov).

Bills Medicare through one group practice

1. Saint Lukes Physician Group IncLeavenworth, KS

Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through) (data.cms.gov).